Video Experimental Relacionado
Updated: Sep 8, 2025
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.8K
Ovatodiolida: avances recientes en las actividades y mecanismos farmacológicos
Yingying Zhou1, Jianguo Zhang1, Qingqing Xia1
1Department of Laboratory Medicine, Taizhou First People's Hospital, Taizhou, China.
Planta medica
|September 5, 2025
Resumen
El Ovatodiolide, un compuesto de Anisomeles indica, se muestra prometedor como agente anticancerígeno y anti-fibrótico al dirigirse a las vías celulares clave. Una mayor investigación de sus mecanismos podría conducir a nuevas aplicaciones terapéuticas.
Área de la Ciencia:
- Química de los productos naturales
- Farmacología
- Química medicinal
Sus antecedentes:
- El Ovatodiolide es un diterpenoide macrocíclico derivado de Anisomeles indica.
- Estudios recientes ponen de relieve su amplio espectro de actividades farmacológicas.
Objetivo del estudio:
- Revisar el descubrimiento, síntesis y acciones farmacológicas de la ovatodiolida.
- Para aclarar los mecanismos moleculares que subyacen a sus efectos terapéuticos.
- Para evaluar su potencial para la traducción clínica.
Principales métodos:
- Revisión de la literatura de las investigaciones existentes sobre la ovatodiolida.
- Análisis de estudios que detallan sus efectos en las vías de señalización.
- Examen de las investigaciones sobre sus propiedades anticancerígenas, antifibróticas, antivirales, antibacterianas y antiinflamatorias.
Principales resultados:
- La ovatodiolida exhibe una actividad antitumoral significativa mediante la modulación de vías como NF-κB/MMP-9, JAK2/STAT3, PI3K/AKT/mTOR y Wnt/β-catenina.
- Se dirige eficazmente a las células madre del cáncer.
- Los efectos antifibróticos están mediados por la supresión de la vía TGF-β y la inhibición de la glucosa-6-fosfato deshidrogenasa.
- Se han demostrado actividades antivirales, antibacterianas y antiinflamatorias.
Conclusiones:
- La ovatodiolida posee diversas propiedades farmacológicas con posibles aplicaciones terapéuticas.
- Comprender sus mecanismos moleculares es crucial para avanzar en su uso clínico.
- Ovatodiolide representa un candidato prometedor para el desarrollo de fármacos.
Videos de Conceptos Relacionados
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.5K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
820
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
820
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
01:24Principles of Drug Action
6.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.6K
01:28Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K